Francesca Colavita to Pandemics
This is a "connection" page, showing publications Francesca Colavita has written about Pandemics.
Connection Strength
0.036
-
COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August-October 2020. Biomolecules. 2021 03 13; 11(3).
Score: 0.008
-
SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February-March 2020. Emerg Infect Dis. 2020 08; 26(8):1842-1845.
Score: 0.007
-
SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection. Ann Intern Med. 2020 08 04; 173(3):242-243.
Score: 0.007
-
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19. Mol Ther. 2021 08 04; 29(8):2412-2423.
Score: 0.002
-
Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay. Viruses. 2020 10 20; 12(10).
Score: 0.002
-
On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. Cell Death Dis. 2020 08 19; 11(8):656.
Score: 0.002
-
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test. J Clin Virol. 2020 08; 129:104539.
Score: 0.002
-
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay. J Clin Virol. 2020 07; 128:104416.
Score: 0.002
-
Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy. Clin Microbiol Infect. 2020 07; 26(7):954-956.
Score: 0.002
-
Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020. Euro Surveill. 2020 03; 25(11).
Score: 0.002